Skip to main content

Scale up your partnering

Showcase your assets, connect with leading pharma firms, track your strategic alliances, scale your partnering activities, and prepare for growth.

Get started

Dedicated to strategic partnerships & growth

+2,000
Biopharma companies
90%
Top 50 pharma
365
Days per year

Accelerate out-licensing activities

“Inpart is really worth the investment, especially once you have 3 or 4 projects to out-license. The amount of time you save is worth far more that the price of a license.”
Business Development Director at Molecure

Connect

Smart matching algorithms and machine learning supervised by human expertise to match assets based on predefined needs and requirements.

Learn more

Network

A premium service with STEM experts to help you get introduced to a vetted network of industry leaders ready to connect and deal.

Learn more

Execute

A CRM that is designed for life science with integrations and templates to streamline your deal tracking process.

Learn more
Asset ProfilesCreate newNameStatusCompFreshnLast updateResminostat (4SC-201)Published60/10040/10011/06/23View on websiteCreate newAngiotensinPublished20/10090/10010/12/23View on websiteCreate newPCSK 9Published90/10080/10019/18/23View on websiteCreate newShowcase an opportunitySearchAll the opportunities

Showcase your company & assets

Increase your visibility and easily inform potential partners about your latest developments without waiting for the next major conference.

Learn more

Get introduced to pharma leaders

Connect with over 6,000 registered industry decision makers and 45/50 top R&D spending companies globally.

Learn more

Attract the right investors

Identify which companies and geographies are interested in your company and assets using the platform's analytics.

Learn more

Advance the right deals, faster

Track valuable connections, foster relationships, explore collaborations and drive success for your partnering initiatives.

About opportunity tracking
Feb, 2 2022Confidential Evalua..Jan, 22 2022Pre-CDA ReviewJan, 20 2022IdentificationNegociationDue DiligenceQualificationPriorityLowConfidenceHighTarget diseaseSelect an optionCodenameTagsRheumathologyAlzheimerMigraineOncologyStatusActiveTasksCreateConfidential EvaluationShare informations of company evaluationSep, 23 2022ALAlbertina LatiShare informations of company evaluationSep, 23 2022ALAlbertina LatiShare informations of company evaluationSep, 23 2022ALAlbertina Lati
Activity streamDue Diligencedue onMar 17, 2023Mar 17, 2023Meghan FlemingMoved toDue DiligenceMar 3, 2023Meghan FlemingMoved toConfidential EvaluationasLicensingFeb 15, 2023Meghan FlemingMoved toPre-CDA ReviewInternal Legal Reviewdue onMar 12, 2023Taylor SheaJan 12, 2023Meghan FlemingCreated inNCF-1913 Out-Licensingfrom sourceNew modalities and drug delivery systemsLast 7 daysEarlierAcceptedScheduledWed, Jun 9, 2023 at 06:00 PMIntroducing BL-658 assetAttended byJamey Stegmaier, Rita ScottWithmbiotechAcceptedScheduledWed, Jun 9, 2023 at 04:30 PMFollow-up meeting with Initech PharmaAttended byJamey Stegmaier, Rita ScottWithInitech Pharmaceuticals

Track your strategic alliances

Track your project status with activity streams, view next steps and report on your activities in seconds.

Learn more

An end-to-end platform for all your partnering needs

Find the ideal partner

Find new experts or industry partners that can guide, co-develop and commercialize your research and assets.

Scale up your partnering activities

Inpart works the way you do, featuring standardized fields and workflows, advanced capabilities such as landscaping, due diligence and alliance management. All of this with a dedicated Customer Success Manager to support you every step of the way.

Find your next partner

Schedule a call with our team of experts to explore the best solution for your partnering needs.

Get started

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2025 Inpart Privacy policy Terms of use